Addex Therapeutics

(NASDAQ) ADXN

Current Price$5.97

Market Cap$6.10M

Since IPO (2020)-98%

5 Year-97%

1 Year-26%

1 Month-9%

Addex Therapeutics Financials at a Glance

Market Cap

$6.10M

Revenue (TTM)

CHF 66.35K

Net Income (TTM)

-CHF 6.73M

EPS (TTM)

-$9.10

P/E Ratio

-0.68

Dividend

$0.00

Beta (Volatility)

0.35 (Low)

Dividend

$0.00

Beta (Volatility)

0.35 (Low)

Price

$5.97

Volume

2,357

Open

$6.50

Price

$5.97

Volume

2,357

Open

$6.50

Previous Close

$6.21

Daily Range

$6.11 - $6.75

52-Week Range

$5.41 - $12.05

Estimated Earnings Date

Jun 15, 2026

Dividend

$0.00

Beta (Volatility)

0.35 (Low)

Price

$5.97

Volume

2,357

Open

$6.50

Previous Close

$6.21

Daily Range

$6.11 - $6.75

52-Week Range

$5.41 - $12.05

Estimated Earnings Date

Jun 15, 2026

ADXN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Addex Therapeutics

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Tim Dyer

Website

www.addextherapeutics.com

Headquarters

Geneva, 1202, CH

ADXN Financials

Key Financial Metrics (TTM)

Gross Margin

-5%

Operating Margin

-18%

Net Income Margin

-44%

Return on Equity

-99%

Return on Capital

-55%

Return on Assets

-1%

Earnings Yield

-1.47%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$6.10M

Shares Outstanding

982.70K

Volume

2.36K

Avg. Volume

4.67K

Financials (TTM)

Gross Profit

CHF 29.97K

Operating Income

-CHF 2.81M

EBITDA

-CHF 6.83M

Operating Cash Flow

-CHF 2.08M

Capital Expenditure

CHF 0.00

Free Cash Flow

-CHF 2.08M

Cash & ST Invst.

CHF 1.64M

Total Debt

CHF 34.73K

Addex Therapeutics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

CHF 248.00

-83.6%

Gross Profit

CHF 248.00

-83.6%

Gross Margin

100.00%

N/A

Market Cap

$6.10M

N/A

Market Cap/Employee

$3.05M

N/A

Employees

N/A

Net Income

-CHF 1.84M

-52.4%

EBITDA

-CHF 1.83M

-57.2%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Total Cash

CHF 1.64M

-51.0%

Total Debt

CHF 34.73K

-17.3%

Accounts Receivable

CHF 20.11K

+29.6%

Inventory

CHF 0.00

N/A

Long Term Debt

CHF 27.04K

-22.1%

Short Term Debt

CHF 7.68K

+5.1%

Return on Assets

-1.06%

N/A

Return on Invested Capital

-54.54%

N/A

Free Cash Flow

-CHF 608.40K

-2482.8%

Operating Cash Flow

-CHF 608.40K

-2482.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

RADXRadiopharm Theranostics Limited

RADXRadiopharm Theranostics Limited$4.43+0.23%

TCRTAlaunos Therapeutics, Inc.

TCRTAlaunos Therapeutics, Inc.$2.20-0.90%

CDIOCardio Diagnostics Holdings, Inc.

CDIOCardio Diagnostics Holdings, Inc.$2.01+1.52%

QNRXQuoin Pharmaceuticals, Ltd.

QNRXQuoin Pharmaceuticals, Ltd.$4.68+1.29%

BCLIBrainstorm Cell Therapeutics Inc.

BCLIBrainstorm Cell Therapeutics Inc.$0.87+2.35%

ADILAdial Pharmaceuticals, Inc.

ADILAdial Pharmaceuticals, Inc.$2.68-2.61%

NRSNNeuroSense Therapeutics Ltd.

NRSNNeuroSense Therapeutics Ltd.$0.74+4.98%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$15.98+0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.90-0.00%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$83.12+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$36.69-0.07%

ONDSOndas

ONDSOndas$9.12+0.00%

BFLYButterfly Network

BFLYButterfly Network$8.20+0.44%

INTCIntel

INTCIntel$133.14+0.10%

Questions About ADXN

What is the current price of Addex Therapeutics?

Addex Therapeutics is trading at $6.31 per share.

What is the 52-week range for Addex Therapeutics?

Over the past 52 weeks, Addex Therapeutics has traded between $5.41 and $12.05.

How much debt does Addex Therapeutics have?

As of the most recent reporting period, Addex Therapeutics reported total debt of CHF 43.78K.

How much cash does Addex Therapeutics have on hand?

Addex Therapeutics reported CHF 2.07M in cash and cash equivalents in its most recent financial results.

What is Addex Therapeutics’s dividend yield?

Addex Therapeutics does not currently have a dividend yield.

Addex Therapeutics

Addex Therapeutics Financials at a Glance

ADXN News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Addex Therapeutics

ADXN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Addex Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ADXN

What is the current price of Addex Therapeutics?

What is the 52-week range for Addex Therapeutics?

How much debt does Addex Therapeutics have?

How much cash does Addex Therapeutics have on hand?

What is Addex Therapeutics’s dividend yield?

Premium Investing Services